DOCSLIB.ORG

Compilers Guide for the International Chemical Safety Cards

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Compilers Guide for the International Chemical Safety Cards Compilers Guide International Chemical Safety Cards 2018 (v1) Compilers Guide for the International Chemical Safety Cards 2018 (v1) ICSC are prepared by an international group of experts on behalf of ILO and WHO, with the financial assistance of the European Commission. © ILO and WHO 2018 page 1 of 141 Compilers Guide International Chemical Safety Cards 2018 (v1) Foreword This is the new Compilers Guide for the International Chemical Safety Cards, an essential tool for making (compiling) ICSC. It has been several years since the transition of the production platform of ICSC, from the so-called PrettyBit (PB) system to the current internet based system). However all this time the makers (compilers) of ICSC have continued to use the ‘manual’ for making ICSC, the Compilers Guide (CG), which in fact is nothing but a Word document. Maintenance of this PrettyBit Compilers Guide (PBCG) was performed in this document and includes activities like adding, editing or deleting (disallowing) standard phrases. But also other activities like adding information regarding GHS classifications and flammability related changes have been recorded in this document. It should also be noted that the PBCG contains several useful appendices with e.g. formulas and tools that can be applied when compiling a card. The most actual version of the CG dates back from August 2010, with beforementioned additions dated February 2012 (titled ‘Compiler's Guide - Updated August 2010 with GHS annotations February 2012’; marked in blue font for GHS-related remarks and in green for flammability-related remarks)). However, keeping the CG up to date not only required meticulous maintenance, but has become increasingly difficult because the PB system had a set up quite different from the current system. For this reason the process of finally converting the PBCG into a new CG designed for the current production database system has been started. A new Compilers Guide In order to create a new Compilers Guide all the essential data from the PBCG has been converted to the current ICSC production database. It is the fruit of the labour over a period of well over a year. For this a new Compilers Guide Committee has been formed. The members of this committee are Bénédicte LaRocca, Daria Pakulska, Marc Baril, Susana Torrado del Rey and Wim Beltman. The maintenance and improvement of the Compilers Guide is a continuous process. The Compilers Guide is not a static document, but a continuously evolving and improving document, which requires both a regular and a regulated process of updating. For this reason other compilers are invited to contact the committee members with any questions or suggestion regarding the Compilers Guide. Any contributions that may improve this CG are very welcome. We are confident that this new CG will be a tremendous step forward in facilitating the compilers’ work and hope you will enjoy this new document. On behalf of the Compilers Guide Committee, Wim Beltman, Scientific Editor ICSC. 27 September 2018. page 2 of 141 Compilers Guide International Chemical Safety Cards 2018 (v1) Table of Contents Foreword ...................................................................................................................................................................... 2 Roadmap ....................................................................................................................................................................... 5 Information format ....................................................................................................................................................... 7 Field name.................................................................................................................................................................................. 7 Grouping of sentences ............................................................................................................................................................... 7 IDENTIFICATION ............................................................................................................................................................ 8 Name .......................................................................................................................................................................................... 8 State ........................................................................................................................................................................................... 8 Synonyms ................................................................................................................................................................................... 9 Mass ........................................................................................................................................................................................... 9 CAS number ............................................................................................................................................................................... 9 UN number .............................................................................................................................................................................. 10 EC number................................................................................................................................................................................ 10 PHYSICAL & CHEMICAL INFORMATION ...................................................................................................................... 11 Formula .................................................................................................................................................................................... 11 Physical properties ................................................................................................................................................................... 11 Physical State; Appearance ...................................................................................................................................................... 19 Physical dangers ....................................................................................................................................................................... 25 Chemical dangers ..................................................................................................................................................................... 28 EXPOSURE & HEALTH EFFECTS ................................................................................................................................... 42 Routes of exposure .................................................................................................................................................................. 42 Inhalation risk .......................................................................................................................................................................... 43 Effects of short-term exposure ................................................................................................................................................ 47 Effects of long-term or repeated exposure ............................................................................................................................. 54 ENVIRONMENT ........................................................................................................................................................... 61 FIRE and EXPLOSION ................................................................................................................................................... 63 Acute hazards........................................................................................................................................................................... 63 Prevention ................................................................................................................................................................................ 68 Fire fighting .............................................................................................................................................................................. 71 EXPOSURE ................................................................................................................................................................... 76 SYMPTOMS - PREVENTION - FIRST AID ...................................................................................................................... 79 Inhalation ................................................................................................................................................................................. 79 Skin ........................................................................................................................................................................................... 85 Eyes .......................................................................................................................................................................................... 91 Ingestion .................................................................................................................................................................................. 96 SPILLAGE DISPOSAL .................................................................................................................................................
Load more

Recommended publications
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • An Improved Process for the Production of Cumene
    Europaisches Patentamt European Patent Office © Publication number: 0 537 389 A1 Office europeen des brevets EUROPEAN PATENT APPLICATION © Application number: 91309531.1 int. Ci.5; C07C 2/66, C07C 2/86, C07C 6/12, C07C 15/085 (§) Date of filing: 16.10.91 ® Date of publication of application: @ Applicant: Council of Scientific and Industrial 21.04.93 Bulletin 93/16 Research Rafi Marg @ Designated Contracting States: New Delhi 110 001 (IN) BE DE FR GB IT NL @ Inventor: Pradhan, Ajit Ramchandra National Chemical Laboratory Pune-411008, Maharashtra(IN) Inventor: Rao, Bollapragad Seshagiri National Chemical Laboratory Pune-411008, Maharashtra(IN) 0 Representative: Collier, Jeremy Austin Grey et al J.A.Kemp & Co., 14 South Square, Gray's Inn London WC1R 5LX (GB) 0 An improved process for the production of cumene. © An improved process is disclosed for the preparation of cumene. Cumene is prepared by reacting benzene with a propylating agent in the presence of a catalyst containing metal loaded Zeolite EU-1 in a reactor in the range of a temperature of 150 to 250 °C and a pressure of 1 to 35 atmospheres, the propyl and diisopropylben- zene so formed are separated from the reactor effluent by conventional methods. The diisopropylbenzene is recycled back to the reactor. Simultaneous alkylation and transalkylation reactions occur in a single catalyst bed containing Zeolite EU-1 with a feed containing benzene, propylene and diisopropylbenzene. Cumenes are important chemical precursors in the production of detergents and polymers among others. Oi CO CO IV CO m Rank Xerox (UK) Business Services (3. 10/3.5x/3.0.
    [Show full text]
  • Toxicological Profile for Carbon Tetrachloride
    CARBON TETRACHLORIDE 1 1. PUBLIC HEALTH STATEMENT This public health statement tells you about carbon tetrachloride and the effects of exposure to it. The Environmental Protection Agency (EPA) identifies the most serious hazardous waste sites in the nation. These sites are then placed on the National Priorities List (NPL) and are targeted for long-term federal clean-up activities. Carbon tetrachloride has been found in at least 430 of the 1,662 current or former NPL sites. Although the total number of NPL sites evaluated for this substance is not known, the possibility exists that the number of sites at which carbon tetrachloride is found may increase in the future as more sites are evaluated. This information is important because these sites may be sources of exposure and exposure to this substance may harm you. When a substance is released either from a large area, such as an industrial plant, or from a container, such as a drum or bottle, it enters the environment. Such a release does not always lead to exposure. You can be exposed to a substance only when you come in contact with it. You may be exposed by breathing, eating, or drinking the substance, or by skin contact. If you are exposed to carbon tetrachloride, many factors will determine whether you will be harmed. These factors include the dose (how much), the duration (how long), and how you come in contact with it. You must also consider any other chemicals you are exposed to and your age, sex, diet, family traits, lifestyle, and state of health.
    [Show full text]
  • Sodium Chloride (Halite, Common Salt Or Table Salt, Rock Salt)
    71376, 71386 Sodium chloride (Halite, Common Salt or Table Salt, Rock Salt) CAS number: 7647-14-5 Product Description: Molecular formula: NaCl Appearance: white powder (crystalline) Molecular weight: 58.44 g/mol Density of large crystals: 2.17 g/ml1 Melting Point: 804°C1 Density: 1.186 g/ml (5 M in water)2 2 Solubility: 1 M in H2O, 20°C, complete, clear, colorless 2 pH: 5.0-8.0 (1 M in H2O, 25°C) Store at room temperature Sodium chloride is geologically stable. If kept dry, it will remain a free-flowing solid for years. Traces of magnesium or calcium chloride in commercial sodium chloride adsorb moisture, making it cake. The trace moisture does not harm the material chemically in any way. 71378 BioUltra 71386 BioUltra for molecular biology, 5 M Solution The products are suitable for different applications like purification, precipitation, crystallisation and other applications which require tight control of elemental content. Trace elemental analyses have been performed for all qualities. The molecular biology quality is also tested for absence of nucleases. The Certificate of Analysis provides lot-specific results. Much of the sodium chloride is mined from salts deposited from evaporation of brine of ancient oceans, or recovered from sea water by solar evaporation. Due to the presence of trace hygroscopic minerals, food-grade salt has a small amount of silicate added to prevent caking; as a result, concentrated solutions of "table salt" are usually slightly cloudy in appearance. 71376 and 71386 do not contain any anti-caking agent. Applications: Sodium chloride is a commonly used chemical found in nature and in all body tissue, and is considered an essential nutrient.
    [Show full text]
  • Transport of Dangerous Goods
    ST/SG/AC.10/1/Rev.16 (Vol.I) Recommendations on the TRANSPORT OF DANGEROUS GOODS Model Regulations Volume I Sixteenth revised edition UNITED NATIONS New York and Geneva, 2009 NOTE The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. ST/SG/AC.10/1/Rev.16 (Vol.I) Copyright © United Nations, 2009 All rights reserved. No part of this publication may, for sales purposes, be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying or otherwise, without prior permission in writing from the United Nations. UNITED NATIONS Sales No. E.09.VIII.2 ISBN 978-92-1-139136-7 (complete set of two volumes) ISSN 1014-5753 Volumes I and II not to be sold separately FOREWORD The Recommendations on the Transport of Dangerous Goods are addressed to governments and to the international organizations concerned with safety in the transport of dangerous goods. The first version, prepared by the United Nations Economic and Social Council's Committee of Experts on the Transport of Dangerous Goods, was published in 1956 (ST/ECA/43-E/CN.2/170). In response to developments in technology and the changing needs of users, they have been regularly amended and updated at succeeding sessions of the Committee of Experts pursuant to Resolution 645 G (XXIII) of 26 April 1957 of the Economic and Social Council and subsequent resolutions.
    [Show full text]
  • Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility Through Gene-Environment Interactions
    toxics Review Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility through Gene-Environment Interactions Dylan J. Wallis 1 , Lisa Truong 2 , Jane La Du 2, Robyn L. Tanguay 2 and David M. Reif 1,* 1 Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA; [email protected] 2 Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA; [email protected] (L.T.); [email protected] (J.L.D.); [email protected] (R.L.T.) * Correspondence: [email protected] Abstract: Exposure to endocrine-disrupting chemicals (EDCs) is linked to myriad disorders, charac- terized by the disruption of the complex endocrine signaling pathways that govern development, physiology, and even behavior across the entire body. The mechanisms of endocrine disruption in- volve a complex system of pathways that communicate across the body to stimulate specific receptors that bind DNA and regulate the expression of a suite of genes. These mechanisms, including gene regulation, DNA binding, and protein binding, can be tied to differences in individual susceptibility across a genetically diverse population. In this review, we posit that EDCs causing such differential responses may be identified by looking for a signal of population variability after exposure. We begin Citation: Wallis, D.J.; Truong, L.; La by summarizing how the biology of EDCs has implications for genetically diverse populations. We Du, J.; Tanguay, R.L.; Reif, D.M. then describe how gene-environment interactions (GxE) across the complex pathways of endocrine Uncovering Evidence for Endocrine- signaling could lead to differences in susceptibility. We survey examples in the literature of individual Disrupting Chemicals That Elicit susceptibility differences to EDCs, pointing to a need for research in this area, especially regarding Differential Susceptibility through the exceedingly complex thyroid pathway.
    [Show full text]
  • Effect of Enzymes on Strawberry Volatiles During Storage, at Different Ripeness
    Effect of Enzymes on Strawberry Volatiles During Storage, at Different Ripeness Level, in Different Cultivars and During Eating Thesis Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in the Graduate School of The Ohio State University By Gulsah Ozcan Graduate Program in Food Science and Technology The Ohio State University 2010 Thesis Committee: Sheryl Ann Barringer, Adviser W. James Harper John Litchfield 1 Copyright by Gülşah Özcan 2010 ii ABSTRACT Strawberry samples with enzyme activity and without enzyme activity (stannous chloride added) were measured for real time formation of lipoxygenase (LOX) derived aroma compounds after 5 min pureeing using selected ion flow tube mass spectrometry (SIFT-MS). The concentration of (Z)-3-hexenal and (E)-2-hexenal increased immediately after blending and gradually decreased over time while hexanal concentration increased for at least 5 min in ground strawberries. The formation of hexanal was slower than the formation of (Z)-3-hexenal and (E)-2-hexenal in the headspace of pureed strawberries. The concentration of LOX aldehydes and esters significantly increased during refrigerated storage. Damaging strawberries increased the concentration of LOX aldehydes but did not significantly affect the concentration of esters. The concentrations of many of the esters were strongly correlated to their corresponded acids and/or aldehydes. The concentration of LOX generated aldehydes decreased during ripening, while fruity esters increased. Different varieties had different aroma profiles and esters were the greatest percentage of the volatiles. The aroma release of some of the LOX derived aldehydes in the mouthspace in whole strawberries compared to chopped strawberries showed that these volatiles are formed in the mouth during chewing.
    [Show full text]
  • ECO-Ssls for Pahs
    Ecological Soil Screening Levels for Polycyclic Aromatic Hydrocarbons (PAHs) Interim Final OSWER Directive 9285.7-78 U.S. Environmental Protection Agency Office of Solid Waste and Emergency Response 1200 Pennsylvania Avenue, N.W. Washington, DC 20460 June 2007 This page intentionally left blank TABLE OF CONTENTS 1.0 INTRODUCTION .......................................................1 2.0 SUMMARY OF ECO-SSLs FOR PAHs......................................1 3.0 ECO-SSL FOR TERRESTRIAL PLANTS....................................4 5.0 ECO-SSL FOR AVIAN WILDLIFE.........................................8 6.0 ECO-SSL FOR MAMMALIAN WILDLIFE..................................8 6.1 Mammalian TRV ...................................................8 6.2 Estimation of Dose and Calculation of the Eco-SSL ........................9 7.0 REFERENCES .........................................................16 7.1 General PAH References ............................................16 7.2 References Used for Derivation of Plant and Soil Invertebrate Eco-SSLs ......17 7.3 References Rejected for Use in Derivation of Plant and Soil Invertebrate Eco-SSLs ...............................................................18 7.4 References Used in Derivation of Wildlife TRVs .........................25 7.5 References Rejected for Use in Derivation of Wildlife TRV ................28 i LIST OF TABLES Table 2.1 PAH Eco-SSLs (mg/kg dry weight in soil) ..............................4 Table 3.1 Plant Toxicity Data - PAHs ..........................................5 Table 4.1
    [Show full text]
  • Transfer of Bromoform Present in Asparagopsis Taxiformis to Milk and Urine of Lactating Dairy Cows
    foods Article Safety and Transfer Study: Transfer of Bromoform Present in Asparagopsis taxiformis to Milk and Urine of Lactating Dairy Cows Wouter Muizelaar 1,2,* , Maria Groot 3 , Gert van Duinkerken 1, Ruud Peters 3 and Jan Dijkstra 2 1 Wageningen Livestock Research, Wageningen University & Research, P.O. Box 338, 6700 AH Wageningen, The Netherlands; [email protected] 2 Animal Nutrition Group, Wageningen University & Research, P.O. Box 338, 6700 AH Wageningen, The Netherlands; [email protected] 3 Wageningen Food Safety Research, Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands; [email protected] (M.G.); [email protected] (R.P.) * Correspondence: [email protected]; Tel.: +31-317-487-941 Abstract: Enteric methane (CH4) is the main source of greenhouse gas emissions from ruminants. The red seaweeds Asparagopsis taxiformis (AT) and Asparagopsis armata contain halogenated compounds, including bromoform (CHBr3), which may strongly decrease enteric CH4 emissions. Bromoform is known to have several toxicological effects in rats and mice and is quickly excreted by the animals. This study investigated the transfer of CHBr3 present in AT to milk, urine, feces, and animal tissue when incorporated in the diet of dairy cows. Twelve lactating Holstein-Friesian dairy cows were randomly assigned to three treatment groups, representing the target dose (low), 2× target dose (medium), and 5× target dose (high). The adaptation period lasted seven days, and subsequently Citation: Muizelaar, W.; Groot, M.; cows were fed AT for 22 days maximally. The transfer of CHBr3 to the urine at days 1 and 10 (10–148 van Duinkerken, G.; Peters, R.; µg/L) was found with all treatments.
    [Show full text]
  • Chapter 1 Tropone and Tropolone
    School of Molecular and Life Sciences New Routes to Troponoid Natural Products Jason Matthew Wells This thesis is presented for the Degree of Doctor of Philosophy of Curtin University November 2018 Declaration To the best of my knowledge and belief this thesis contains no material previously pub- lished by any other person except where due acknowledgement has been made. This thesis contains no material which has been accepted for the award of any other degree or diploma in any other university. Signature: Date: i Abstract Malaria is an infectious disease found in humans and other animals, it is caused by a single-cell parasite of the Plasmodium genus with many different substrains. Of these, P. falciparum is the most deadly to humans causing the majority of deaths. Although research into the area of antimalarial compounds is wide spread, few have been devel- oped with new structural features. Cordytropolone 37 is a natural product isolated in 2001 from the insect pathogenic fungus Cordyceps sp. BCC 1681 and has been shown to have antimalarial activity against P. falciparum. It has a structure unrelated to antimalarial com- pounds currently used in therapy. It does not contain a peroxide bridge as with artemisinin 25 or quinoline rings as with chloroquine 22. This unique structure indicates that it could possibly interact with the malaria parasite in a fashion unlike current treatments. In order for cordytropolone to be further developed as a potential treatment, it must first be synthe- sised in a laboratory environment. This study attempts to develop the first total synthesis of cordytropolone. H HO O N O O N O N H H H O O Cl HO O 22 25 37 Figure 0.0.1: Cordytropolone 37 has a unique structure compared to the current common malaria treatments The first method investigated towards the total synthesis of cordytropolone involved an intramolecular Buchner ring expansion.
    [Show full text]
  • Comparative Durability and Abrasion Resistance of Natural and Synthetic
    Comparative Durability and Abrasion Resistance of Natural and Synthetic Latex Gloves Ryan Michel2 and Katrina Cornish1,2 Department of Horticulture and Crop Science, 2Department of Food, Agricultural and Biological Engineering, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, OH 44691 Abstract Medical gloves assist with the prevention of the spread of germs and are required to be worn when working with blood, body tissues, mucous membrane, and broken skin. They should provide good protection between hands and bio hazardous fluids to prevent contamination and promote safety of all healthcare workers and patients. Hence, it is critical for medical gloves to meet a standard performance criterion. Under ASTM D 3577 and D 3578, medical gloves have requirements they must meet in order to be sold and distributed as new gloves. However, there are no industry standards for gloves to meet while in use. The goal of this project was to develop a standard test for glove durability after their initial use. For the tests, gloves were worn by a mechanized prosthetic hand that was put under different conditions which are normally experienced by professionals in the medical field. This design was developed and later confirmed by Dr. Katrina Cornish: Design: Effects of media outside the glove Phosphate buffered saline (PBS), 70% ethanol, air Gloves Tested: Chloroprene, Latex 2, Nitrile, Polyvinyl Chloride and Latex 1 To evaluate glove durability during use, the gloves were immersed in different media before being subjected to contact with an abrasive surface. From this design, ranking of commercially available gloves are developed based on the time until failure of the gloves in these tests.
    [Show full text]
  • Cancer Drug Pharmacology Table
    CANCER DRUG PHARMACOLOGY TABLE Cytotoxic Chemotherapy Drugs are classified according to the BC Cancer Drug Manual Monographs, unless otherwise specified (see asterisks). Subclassifications are in brackets where applicable. Alkylating Agents have reactive groups (usually alkyl) that attach to Antimetabolites are structural analogues of naturally occurring molecules DNA or RNA, leading to interruption in synthesis of DNA, RNA, or required for DNA and RNA synthesis. When substituted for the natural body proteins. substances, they disrupt DNA and RNA synthesis. bendamustine (nitrogen mustard) azacitidine (pyrimidine analogue) busulfan (alkyl sulfonate) capecitabine (pyrimidine analogue) carboplatin (platinum) cladribine (adenosine analogue) carmustine (nitrosurea) cytarabine (pyrimidine analogue) chlorambucil (nitrogen mustard) fludarabine (purine analogue) cisplatin (platinum) fluorouracil (pyrimidine analogue) cyclophosphamide (nitrogen mustard) gemcitabine (pyrimidine analogue) dacarbazine (triazine) mercaptopurine (purine analogue) estramustine (nitrogen mustard with 17-beta-estradiol) methotrexate (folate analogue) hydroxyurea pralatrexate (folate analogue) ifosfamide (nitrogen mustard) pemetrexed (folate analogue) lomustine (nitrosurea) pentostatin (purine analogue) mechlorethamine (nitrogen mustard) raltitrexed (folate analogue) melphalan (nitrogen mustard) thioguanine (purine analogue) oxaliplatin (platinum) trifluridine-tipiracil (pyrimidine analogue/thymidine phosphorylase procarbazine (triazine) inhibitor)
    [Show full text]